Search results
Earnings call: Eisai Co. Ltd. maintains steady revenue with a focus on Alzheimer's treatment By...
Investing.com· 8 hours agoThe pharmaceutical giant emphasized its success with key products, especially in the Alzheimer's...
Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's Treatment
Investor's Business Daily· 2 days agoThere are about 5,000 patients receiving Leqembi for early Alzheimer's treatment. In the fourth...
Most cancer treatments are useless for patients with advanced tumors near end of life
UPI· 4 hours agoCutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new...
...LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early ...
WTNH-TV New Haven· 3 days agoLEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia ...
AriBio receives approval from China’s NMPA to begin Alzheimer’s treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe Polaris-AD trial will enrol patients at up to 20 trial sites in China, keeping the same...
Study shows vicious cycle of protein clumping in Alzheimer's disease and normal aging
Medical Xpress· 23 hours agoTo date, approaches to treatments for Alzheimer's disease have not addressed the contribution of protein insolubility as a general phenomenon ...
Breakthrough Alzheimer's Treatment Featured In New Boomers Today Podcast Episode
Digital Journal· 2 days agoAlzheimer's disease affects millions of individuals worldwide, posing significant challenges for patients, families, and healthcare professionals. It is ...
New research presents 'mini-brains' that could advance Alzheimer's treatment
Medical Xpress· 3 days agoTyler Wenzel (Ph.D.) first came up with the idea of building a miniature brain from stem cells, he...
Lilly girding for questions over Alzheimer's treatment from FDA committee - Indianapolis Business...
Indianapolis Business Journal· 5 days agoIt’s been a roller-coaster ride for three decades at Eli Lilly and Co. in trying to develop a ...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
FOX 4 Kansas City· 3 days agoIn the US, Leqembi is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild...